Nerve Growth Factor and Brain-Derived Neurotrophic Factor in Human Paediatric Hemimegalencephaly

Abstract

Paediatric hemimegalencephaly (HME) is a congenital central nervous system (CNS) disorder, characterized by monolateral cerebral hemisphere enlargement, intractable seizures starting in the post-neonatal period, and mental retardation associated with neuropathological anomalies (mainly cortical thickness and lack of lamination). Nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) are two neurotrophic factors produced in the mammalian CNS that are involved in the survival, development, and function of a variety of brain cells. In the present study, we found increased cerebral tissue levels of NGF and BDNF in 4 infants with HME; these changes appear to be also associated with abnormal NGF-receptor expression in subcortical blood vessels. Moreover, the marked reduction of cortical choline acetyltransferase immunoreactivity is strongly suggestive of a dysregulation in the NGF differentiative activity in this site that could lead to the pathogenesis of HME.

Hemimegalencephaly - NGF - BDNF - choline acetyltransferase - NGF-receptors

References

• 1 Alderson R F, Alterman A L, Barde Y A, Lindsay R M. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture.  Neuron. 1990;  5 297-306
• 2 Aloe L, Bracci-Laudiero L, Bonini S, Manni L. The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases.  Allergy. 1997;  52 883-994
• 3 Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut R E. The role of endogenous nerve growth factor in human diabetic neuropathy.  Nature Med. 1996;  2 703-707
• 4 Auld D S, Mennicken F, Day J C, Quirion R. Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons.  J Neurochem. 2001;  77 253-262
• 5 Bernabei R, Landi F, Bonini S, Onder G, Lambiase A, Pola R, Aloe L. Tropical application of nerve growth factor accelerates healing of pressure ulcer in humans.  Lancet. 1999;  354 182-185
• 6 Bosman C, Boldrini R, Dimitri L, Di Rocco C, Corsi A. Hemimegalencephaly. Histological, immunohistochemical, ultrastructural and cytofluorimetric study of six patients.  Child's Nerv System. 1996;  12 765-775
• 7 Bowes M, Tuszynski M H, Conner J, Zivin J A. Continuous intrathecal fluid infusion elevate Nerve Growth factor levels and prevent functional deficits after spinal cord ischemia.  Brain Res. 2000;  883 178-183
• 8 Cimino M, Cattabeni F, Di Luca M, Peruzzi G, Andena M, Tirassa P, Angelucci F, Cozzari C, Aloe L. Levels of NGF, P75 NGFR and Chat immunoreactivity in brain of adult and aged microencephalic rats.  Neurobiol Aging. 1996;  7 146-149
• 9 Chen E Y, Mufson E J, Kordower J H. TRK and P75 neurotrophin receptor system in the developing human brain.  J Comp Neurol. 1996;  369 591-618
• 10 Clancy R R, Kurtz M B, Baker D, Sladky J T, Honig P J, Younkin D P. Neurological manifestations of the organoid nevus syndrome.  Arch Neurol. 1985;  42 236-240
• 11 Connor B, Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain.  Brain Res Rev. 1998;  27 1-39
• 12 Dambska M, Wisniewski K, Sheik J. An autopsy case of hemimegalencephaly.  Brain Dev. 1984;  6 60-64
• 13 De Rosa M J, Secor D L, Barsom M, Fisher R S, Vinters H V. Neuropathologic findings in surgically treated hemimegalencephaly.  Acta Neuropathol. 1992;  84 250-260
• 14 Dixon C E. Nerve growth factor attenuates cholinergic deficits following traumatic brain injury in rats.  Experimental Neurol. 1997;  146 479
• 15 Dobyns W B, Reiner O, Carrozzo R, Ledbetter D H. A human brain malformation associated with delection of L1S1 gene located at chromosome 17 p13.  JAMA. 1993;  270 2838-2842
• 16 Greene L A, Tischler A S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.  Proc Natl Acad Sci USA. 1976;  73 2424-2428
• 17 Hirashima Y, Endo S, Karasawa K, Sato N, Yokoyama K, Kurimoto M, Ikeda H, Setaka M, Takaku A. Deficient platelet-activating factor and related enzymes in hemimegalencephaly.  Child's Nerv System. 1999;  15 98-102
• 18 Hyman C, Hofer M, Barde Y A, Juhasz M, Yancopoulos G D, Squinto S P, Lindsay R M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.  Nature. 1991;  350 230-232
• 19 Kato M, Mizuguchi M, Sakuta R. Hypertrophy of the cerebral white matter in hemimegalencephaly.  Pediatr Neurol. 1996;  14 335-338
• 20 Korhonen L, Raili R, Hiroyuki N, Lidholm D. Brain derived neurotrophic factor is increased in cerebrospinal fluid of children suffering from asphyxia.  Neuroscience Letters. 1998;  240 151-154
• 21 Lambiase A, Rama P, Bonini St, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers.  N Engl J Med. 1998;  338 1174-1180
• 22 Levi-Montalcini R. The nerve growth factor 35 years later.  Science. 1987;  237 1154-1162
• 23 Mamounas L A, Blue M E, Siuciak J A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain.  J Neurosci. 1995;  15 7929-7939
• 24 Meakin S O, Shooter E M. The nerve growth factor family of receptors.  Trends Neurosci. 1992;  15 323-331
• 25 Molnar M, Tongiorgi E, Avignone E, Gonfloni S, Ruberti F, Domenici L, Cattaneo A. The effects of anti-nerve growth factor monoclonal antibodies on developing basal forebrain neurons are transient and reversible.  Eur J Neurosci. 1998;  10 3127-3140
• 26 Nakahashi T, Fujimura H, Altar C A, Li J, Kambayashi J, Tandon N N, Sun B. Vascular endothelial cells synthetise and secrete brain-derived neurotrophic factor.  FEBS Lett. 2000;  470 113-117
• 27 Shimohama S, Tamura Y, Akaike A, Tsukahara T, Iwata H, Kimura J. Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons.  Neurosci Lett. 1993;  164 55-58
• 28 Siegel G J, Chauhan N B. Neurotrophic factors in Alzheimer's and Parkinson's disease brain.  Brain Res Rev. 2000;  33 199-227
• 29 Snider W D, Johnson Jr E M. Neurotrophic molecules.  Ann Neurol. 1989;  26 489-506
• 30 Sofroniew M V, Howe C L, Mobley W. Nerve growth factor signalling, neuroprotection, and neural repair.  Ann Rev Neurosci. 2001;  24 1217-1281
• 31 Spenger C, Hyman C, Studer L, Egli M, Evtouchenko L, Jackson C, Dahl-Jorgensen A, Linsday R M, Seiler R W. Effects of BDNF on dopaminergic, serotonergic, and GABAergic neurons in cultures of human fetal ventral mesencephalon.  Exp Neurol. 1995;  133 50-63
• 32 Tirassa P, Manni L, Stenfors C, Aloe L. RT-PCR ELISA method for the analysis of neurotrophin mRNA expression in brain and peripheral tissues.  J Biotechnol. 2000;  84 259-272
• 33 Tuveri M, Generine S, Matucci-Cenerini M, Aloe L. Nerve growth factor, an useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis.  Lancet. 2000;  356 1739-1740
• 34 Vanhala R, Korhonen L, Mikelsaar M, Lindholm D, Riikonen R. Neurotrophic factors in cerebrospinal fluid and serum of patients with Rett syndrome.  J Child Neurol. 1998;  13 429-433
• 35 Ventimiglia R, Mather P E, Jones B E, Linsday R M. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro.  Eur J Neurosci. 1995;  7 213-222
• 36 Villoslada P, Hauser S L, Bartke I, Unger J, Heald N, Rosemberg D, Cheung S W, Mobley W C, Fisher S, Genain C P. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system.  J Exp Med. 2000;  191 1799-1806
• 37 Weskamp G, Otten U. An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and peripheral tissues.  J Neurochem. 1987;  48 1779-1786